Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001674416-16-000002
Filing Date
2016-11-04
Accepted
2016-11-04 13:31:19
Documents
1
Effectiveness Date
2016-11-04
Items
Item 06c:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 14873
  Complete submission text file 0001674416-16-000002.txt   15941
Mailing Address AESCHENVORSTADT 36 BASEL V8 4051
Business Address AESCHENVORSTADT 36 BASEL V8 4051 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

EIN.: 473173478 | State of Incorp.: V8
Type: D | Act: 33 | File No.: 021-273840 | Film No.: 161974548
SIC: 2836 Biological Products, (No Diagnostic Substances)